Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(21 sites)
United States
Cardiology and Medicine Clinic, Little Rock, Arkansas National Institute of Clinical Research, Huntington Beach, California FOMAT, Santa Maria, California Invivocure LLC, Van Nuys, California New Generation of Medical Research, Hialeah, Florida Jacksonville Center for Clinical Research, Jacksonville, Florida Amavita Health, North Miami Beach, Florida Broward Research Center, Pembroke Pines, Florida Eagle Clinical Research, Chicago, Illinois Chicago Medical Research, Hazel Crest, Illinois Methodist Medical Center of Illinois, Peoria, Illinois Louisiana Heart Center, Slidell, Louisiana Washington University, St Louis, Missouri Ash Research Clinic, Brick, New Jersey Erie County Medical Center, Buffalo, New York Duke University Medical Center, Durham, North Carolina Wake Forest, Winston-Salem, North Carolina Cleveland Clinic, Cleveland, Ohio Oklahoma Heart Hospital, Oklahoma City, Oklahoma University of Texas Southwestern Medical Center, Dallas, Texas LinQ Research, LLC, Tomball, Texas